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Summary
Aging is associated with alterations in the content and patterns
of DNA methylation virtually throughout the entire human
lifespan. Reasons for these variations are not well understood.
However, several lines of evidence suggest that the epigenetic
instability in aging may be traced back to the alteration of the
expression of DNA methyltransferases. Here, the association of
the expression of DNA methyltransferases DNMT1 and DNMT3B
with age has been analysed in the context of the MARK-AGE
study, a large-scale cross-sectional study of the European general
population. Using peripheral blood mononuclear cells, we
assessed the variation of DNMT1 and DNMT3B gene expression
in more than two thousand age-stratified women and men (35–
75 years) recruited across eight European countries. Significant
age-related changes were detected for both transcripts. The level
of DNMT1 gradually dropped with aging but this was only
observed up to the age of 64 years. By contrast, the expression of
DNMT3B decreased linearly with increasing age and this associ-
ation was particularly evident in females. We next attempted to
trace the age-related changes of both transcripts to the influence
of different variables that have an impact on changes of their
expression in the population, including demographics, dietary
and health habits, and clinical parameters. Our results indicate
that age affects the expression of DNMT1 and DNMT3B as an
almost independent variable in respect of all other variables
evaluated.
Key words: aging; DNA methylation; DNMT1; DNMT3B.
Introduction
Epigenetic processes are a molecular interface that mediates the
interaction between genome and environment during the entire
lifespan of organisms. Aberrant epigenetic signalling, including DNA
methylation defects, plays a crucial role in aging (Zampieri et al.,
2015). The understanding of the mechanisms behind these events is
an important research topic as it can reveal the molecular mechanisms
contributing to age-associated physiological decline and disease.
DNA methylation is a modification of the genome that occurs after
DNA replication by the attachment of a methyl group to the cytosine
of a CpG dinucleotide. In mammals, 5-methylcytosine (5mC) repre-
sents an epigenetic modification of the genome that marks transcrip-
tionally repressed domains and serves as a heritable signal sufficient to
restore silent chromatin following DNA replication (Bird, 2002). In the
human genome, almost 80% of the CpGs are methylated in
nonrandom fashion with the remaining unmethylated residues pref-
erentially restricted to CpG islands (CGIs) within gene promoters
(Deaton & Bird, 2011). This bimodal pattern is established during
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development and differentiation when tissue-specific changes in DNA
methylation shape the epigenetic patterns of each individual cell type.
This accomplishes transcriptional repression of repetitive DNA
sequences and allows housekeeping genes to be expressed, but it
also provides long-term stability to the tissue-specific gene expression
profile of somatic cells.
DNA methylation patterns are dynamic states balanced by methyla-
tion and demethylation processes. The ‘maintenance methyltransferase’
DNMT1 mainly maintains the methylation patterns across replication
cycles while the de novo DNMT3A and DNMT3B enzymes mainly
introduce methyl groups onto DNA at sites that had been unmethylated
(Jurkowska et al., 2011).
Regarding DNA demethylation, both passive and active processes
have been proposed. Passive demethylation includes everything that
negatively affects DNA methyltransferase action, thus leading to the
loss of 5mC marks on the genome during DNA replication. However,
evidence has been accumulated indicating the existence of replication-
independent active DNA demethylation involving 5-hydroxymethylcy-
tosine formation and DNA repair mechanisms (Sch€ubeler, 2015).
Several studies have clearly demonstrated that distinct DNA methy-
lation changes highly correlate with aging throughout the entire lifespan
of humans and mice. Collectively, these studies have shown that aging,
similar to cancer, is associated with gradual but profound changes in
DNA methylation where the epigenome is marked by global hypomethy-
lation together with an opposite process of focal hypermethylation
preferentially at CGI promoters (Issa, 2014).
These phenomena erode the normal genomic methylation patterns
leading to divergent methylomes in the normal population as a
function of chronological age. However, directional changes in specific
regions in aged individuals occur in the context of age-associated
increase of DNA methylation entropy and this process is commonly
defined as ‘epigenetic drift’ (Fraga et al., 2005). Although the
presence of an aberrant DNA methylation signalling and its outcome
in aging progression are well described, the underlying molecular
mechanisms are far from being understood.
Transcriptional control of DNA methyltransferases (DNMTs) can be
responsible for changes in protein level or enzymatic activity both in
physiological and in pathological conditions (Tsai et al., 2012; Calabrese
et al., 2014). Previous studies indicate that aging affects the expression
of DNMTs, suggesting this as being one of the mechanisms involved in
the deregulation of the methylation patterns observed in aging.
However, these observations derive from very few studies analysing
relatively small sample sizes (Zhang et al., 2002; Casillas et al., 2003;
Balada et al., 2008; Xiao et al., 2008; Li et al., 2010; Qian & Xu, 2014).
Here, we report results from an European large-scale cross-sectional
study aimed at investigating the association of DNMTs expression with
age as part of the MARK-AGE project.
MARK-AGE is a European-wide population study, supported by the
European Commission (FP7), aiming to discover biomarkers of aging
which would serve as a reliable measure of biological age (B€urkle et al.,
2015; Capri et al., 2015).
We measured the transcript levels of DNMT1 and DNMT3B genes and
analysed their variation with age in peripheral blood mononuclear cells
(PBMCs) from more than two thousand age-stratified donors
(35–75 years) from the general population from eight European
countries (Capri et al., 2015).
Our data show that age has an influence on the expression of DNMT1
and DNMT3B genes in PBMCs. This interaction does not significantly
depend on nutritional, lifestyle and clinical variables influencing the
expression of DNMTs in the population.
Results
Characteristics of the study population
The analysis of the transcript levels of DNMT1 and DNMT3B was carried
out on PBMCs from blood samples obtained from donors (2453
individuals) from eight European countries (Table 1).
The largest group of samples consisted of the RASIG (Randomly-
Recruited Age-Stratified Individuals from the General population),
representing individuals undergoing a normal aging process.
Offspring of nonagenarians previously studied in the GEHA study
(Genetics of Healthy Ageing; Franceschi et al., 2007) and termed GO
(‘GEHA offspring’) were also recruited as a potential model of ‘retarded
aging’, based on the assumption that their genetic background may
predispose them to longevity. As a control for environmental factors and
lifestyle, recruitment of GO was accompanied by the recruitment of their
spouses, termed SGO (‘spouses of the GO’) (B€urkle et al., 2015; Capri
et al., 2015).
MARK-AGE subjects covered the age range between 35 and 75 years
and were stratified into four 10-year age groups. The age distribution of
RASIG individuals was almost homogeneous, while GO and SGO
individuals fell into age ranges > 54 years. The composition of male
and female individuals was mainly comparable in all age groups, albeit
female representation was a few percentage points larger than males. In
agreement with literature data studying subjects in the age range 35–
75 years, the body mass index (BMI) appeared to increase with age
indicating that the analysed population was effectively representative of
a physiological aging process. The characteristics of the study population
referred to each recruiting centre are reported in Table S1 (Supporting
information).
Identification of outliers and distribution tests
Due to positively skewed values, DNMT1 and DNMT3B expression data
failed to pass the Kolmogorov–Smirnov test for normal distribution. We
also identified data of DNMT1 mRNA (three samples) with values above
89 the interquartile range, which were considered outliers and excluded
in all parametric analyses (but included in nonparametric tests, for
example Spearman correlation and Kruskal–Wallis, which are not
sensitive to few outliers). After removal of outliers, the DNMT1
expression data still failed to pass normality tests. Hence, we analysed
Q-Q plots of the log-transformed and not-transformed variables of
DNMT1 and DNMT3B to establish the distribution that best represented
our data. On the basis of our analysis, the distributions that better
represented data were gamma distribution for DNMT1 and normal
distribution for log-transformed DNMT3B data (Fig. S1, Supporting
information). However, since the optimal distribution was not identified,
we performed both parametric and nonparametric tests to verify the
robustness of results.
Expression levels of DNMT1 and DNMT3B transcripts with
respect to age and demographics
In the RASIG samples, we identified nonlinear but significant changes of
DNMT1 in age groups by parametric and nonparametric tests. DNMT1
transcript decreased gradually below 64 years of age, transiently
achieving a significant reduction in the 55–64 vs. the 35–44 age group
before returning to levels comparable to the under-54 in individuals over
the age of 65 years. Regarding DNMT3B, its expression appeared to
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decrease linearly with age, with a significant reduction in the two oldest
age classes compared to the first one (Table 2). Graphical representation
of DNMT1 and DNMT3B data describes better the minimal, but
significant age-related changes observed in the samples. In particular,
DNMT3B displayed a significant linear decrease with age, while DNMT1
displayed a U-shaped bimodal pattern. This U-shaped bimodal pattern
for DNMT1 mRNA variation with age was less evident when the samples
were analysed as a whole (RASIG together with GO and SGO samples)
due to a lack of significance for the recovery of transcript levels in the
oldest age group compared to younger age groups. Regarding DNMT3B,
its reduction with increasing age was independent of the inclusion of GO
and SGO in the analysis (Fig. S2).
Association between age and DNMTs transcript levels in the RASIG
population was further tested by correlation analyses. DNMT3B showed
a weak negative linear correlation with age. However, this association
remained significant only in females when the samples were split based
on gender. The same analysis confirmed that the association of DNMT1
with age was not linear when tested over the entire age range, which is
in line with the U-shaped trend of DNMT1 variation with age.
Consistently, a quadratic relationship between DNMT1 and age showed
a better fit to the data than the linear one, which was, instead,
significant and negative for both genders when individuals over the age
of 65 years were excluded from the analysis (Fig. 1). The level of
expression of both DNMT1 and DNMT3B was dissimilar across the
different European countries (Table 2). Moreover, the expression levels
across age groups within each recruitment centre were significantly
different for part of them probably as a consequence of the high
variability, gender-specific effects and the relative lower sample size of
each centre compared to the overall sample (Table S2).
Table 2 also shows that both the DNMT1 and DNMT3B mRNA
expression were significantly higher in females compared to males. This
association with gender was evident for DNMT1 only by the generalized
linear model (GLM) test that includes age and country as covariates,
suggesting these variables as confounding factors in the nonparametric
test. The same conclusions can be drawn for the positive association
observed between DNMT3B expression and BMI.
Investigation of variables (lifestyle, dietary habits,
haematological parameters and cardiovascular risk factors)
that potentially affect DNMT1 and DNMT3BmRNA expression
From all subjects enrolled in the MARK-AGE project, a large number of
anthropometric and medical data were collected. In a preliminary
analysis, we evaluated variables that might have a potential impact on
DNMT1 and DNMT3B expression, including dietary and lifestyle habits,
haematological parameters, and cardiovascular or diabetes risk factors.
Several variables were found to be associated with DNMTs expression by
nonparametric Kruskal–Wallis (KW) test only. In fact, many of these
associations were disproved or blunted by GLM which included the
effects of gender, recruitment centre and age as covariates (See Tables
S3–S5). Such evidence indicates that those associations with DNMTs
expression, reported by KW analysis, were indirect. Examples of such
discordance include the associations of DNMT1 expression with French
fries and brown bread consumption or with glucose and homocysteine
blood levels.
Based on the congruence between KW and GLM tests, a limited set of
variables appeared to be consistently associated with the expression of
DNMTs. Apart from a link between weekly consumption of white bread
and DNMT1mRNA levels, no association with other self-reported dietary
habits was detected (Table S3). This also concerns consumption of
alcoholic beverages and smoking habits as well as cardiovascular and
diabetes risk biomarkers (Table S4). As far as haematological parameters
are concerned (Table S5), DNMT1 and DNMT3B mRNAs were less
expressed with increasing monocyte counts. Instead, only DNMT1 was
Table 1 Characteristics of the study population by age groups†
Age groups All 1 2 3 4
P
Age range (years) 35–75 35–44 45–54 55–64 65–75
N 2453 383 484 807 779
Age (years) 57.6  10.7 39.6  2.8 49.6  2.8 59.9  2.8 69.0  3.0 < 0.001
Male % (n) 47 (1145) 46 (177) 47 (226) 45 (366) 48 (376) 0.707
Smoker, never 52 (1264) 59 (227) 48 (233) 49 (393) 53 (401) < 0.001
Former 34 (826) 17 (66) 33 (162) 37 (297) 39 (301)
Current 15 (363) 23 (90) 18 (89) 14 (117) 9 (67)
Group, GO 18 (437) 0 (1) 3 (17) 25 (205) 28 (214) < 0.001
RASIG 72 (1774) 99 (381) 93 (449) 60 (483) 59 (461)
SGO 10 (242) 0 (1) 4 (18) 15 (119) 13 (104)
BMI (kg/m2) 26.3  4.5 24.9  4.6 25.6  4.4 26.7  4.5 27.0  4.3 < 0.001
< 25 43 (1059) 59 (226) 50 (244) 39 (317) 35 (272)
25 to < 30 39 (957) 28 (109) 35 (171) 41 (331) 44 (346) < 0.001
≥ 30 18 (436) 12 (48) 14 (69) 20 (159) 21 (160)
Finland 10 (249) 2 (9) 4 (18) 13 (109) 14 (113)
Italy 20 (485) 26 (98) 22 (105) 18 (144) 18 (138)
Austria 11 (267) 18 (69) 14 (69) 9 (69) 8 (60)
Greece 13 (317) 18 (71) 16 (78) 11 (86) 10 (82) < 0.001
Poland 11 (270) 12 (46) 11 (52) 12 (99) 9 (73)
The Netherlands 8 (189) 0 (0) 1 (3) 10 (79) 14 (107)
Belgium 14 (350) 8 (30) 14 (69) 16 (131) 15 (120)
Germany 13 (326) 16 (60) 18 (90) 11 (90) 11 (86)
†Values are mean  SD and percentage (number), all such variables; one missing case for BMI; P-value: one-way ANOVA (continuous variables) and chi-square test
(prevalence). Definition of abbreviations is provided in the Data S2.
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expressed more in samples characterized by an increased number of
lymphocytes and of higher lymphocytes/monocytes ratio. This was even
more evident when looking at the T lymphocyte (CD3+CD45+) content,
which also showed a positive association with DNMT3B. DNMT1 was
also less expressed in samples characterized by an increased amount of
neutrophils, while DNMT3B showed an increasing trend with increasing
number of platelets. Of note, the relationship of DNMTs expression levels
in PBMCs with lymphocytes and monocytes blood counts mostly
resembles the higher expression of these genes in lymphocytes subtypes
with respect to monocytes, as revealed by the analysis of publicly
available microarray expression data (Su et al., 2004) (Fig. S3).
Similar results were obtained by analysing the whole population of
samples (RASIG together with GO and SGO samples) (Table S6).
Contribution of selected variables on age-related changes of
DNMT1 and DNMT3B mRNA expression in the RASIG
population
GLM and regression analyses were used to determine whether the age-
related changes observed for DNMT1 and DNMT3B genes are an intrinsic
feature of the aging process or whether one or more of the variables
shown to influence their expression can justify these changes.
As shown in Table 3, the changes of DNMT1 expression in age groups
seem to depend on a combined impact of multiple parameters rather
than on a specific one. However, the age-related variations of DNMT1
mRNA levels remained significant even when considering all the variables
that significantly affected DNMT1 expression (i.e. showing a significant
interaction with DNMT1 expression as detected by both KW and GLM
tests, see Table 2 and Tables S3–S5), indicating that the analysed
parameters cannot fully explain the DNMT1 transcript differences
observed between age groups. To confirm the result, several additional
models were run with progressive inclusion of variables categorized on
the basis of any significant association with DNMT1 expression, also
including only those identified by KW test (Tables S7A and B). Further
analysis using the log-transformed values of DNMT1 yielded comparable
data (Table S8A and B).
Similar results concerned the age-related variation of DNMT3B
transcript. Its linear decrease with age (Table 2 and Fig. 1) allowed the
investigation by regression analysis. Taking into account the gender
difference identified in Fig. 1, we performed a separate analysis for
gender. The analysis confirmed the linear decrease of DNMT3B mRNA
levels in females (but not males). The linear decrease of DNMT3B in the
females was not affected by the inclusion of other variables associated
with differences in DNMT3B mRNA levels between individuals (Table 4).
Identification of major variables affecting the measurement
of DNMT1 and DNMT3B expression
Decision tree analysis including all variables with at least one significant
effect on DNMT1 and DNMT3B (see Table 2 and Tables S3–S5) was
performed to identify the major factors affecting DNMTs expression. We
identified the recruitment centre and the lymphocyte-to-monocyte ratio
Table 2 Effect of age, gender, BMI on DNMT1 and DNMT3B expression in the RASIG population
Stat N
DNMT1 DNMT3B
Median (IQ) P (KW)† P (GLM)‡ Median (IQ) P (KW)† P (GLM)‡
Age group (years)
35–44 a 381 0.134 (0.102–0.171)c 0.003 0.049 0.022 (0.017–0.029)c,d 0.004 0.030
45–54 b 449 0.129 (0.095–0.159) 0.021 (0.016–0.029)
55–64 c 483 0.117 (0.088–0.165)a,d 0.020 (0.015–0.027)a
65–75 d 461 0.129 (0.095–0.171)c 0.020 (0.015–0.026)a
Centre
Finland a 80 0.125 (0.092–0.154)b < 0.001 < 0.001 0.024 (0.018–0.031)g < 0.001 < 0.001
Italy b 362 0.144 (0.113–0.183)a,c,d,g,h 0.020 (0.015–0.025)c
Austria c 267 0.113 (0.080–0.165)b,e 0.023 (0.015–0.035)b.g
Greece d 296 0.129 (0.095–0.171)b,g 0.021 (0.016–0.031)g
Poland e 202 0.139 (0.105–0.177)c,g 0.022 (0.016–0.028)g
The Netherlands f 0 – –
Belgium g 241 0.109 (0.077–0.139)b,d,e,h 0.017 (0.014–0.024)a,c,d,e
Germany h 326 0.129 (0.102–0.159)b,g 0.020 (0.016–0.027)
Gender
F a 940 0.129 (0.098–0.165) 0.056 0.031 0.021 (0.016–0.029)b 0.001 0.002
M b 834 0.125 (0.092–0.165) 0.020 (0.015–0.027)a
BMI classes
< 25 a 810 0.125 (0.095–0.165) 0.047 0.377 0.020 (0.015–0.028) 0.078 0.019
25 to < 30 b 662 0.125 (0.092–0.165) 0.021 (0.016–0.027)
≥ 30 c 301 0.139 (0.102–0.171) 0.022 (0.016–0.028)
†KW test: nonparametric comparison by the Kruskal–Wallis test of DNMT1 and DNMT3B mRNAs levels (data for two group comparison are analysed with the Mann–
Whitney U-test); data are reported as median and interquartile range (IQ). Pairwise comparisons are referred to the KW test and adjusted for multiple comparisons
(comparisons with P < 0.05 are marked by the associated superscripts).
‡GLM: comparison by generalized linear models of DNMT1 (gamma distribution with log-link function model) and DNMT3B (linear model with log-transformed values and
identity link function) mRNAs levels. For the investigation of age-group effects, the model included the effects of gender and recruitment centre as factors. All other GLM
models included the effects of gender, recruitment centre and age (continuous variable) as covariate (only P values for the selected variables are shown). Definition of
abbreviations is provided in the Data S2.
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as being the most important factors that affect both DNMT1 (Fig. S4)
and DNMT3B (Fig. S5). Minor subgroups were identified on the basis of
age, WBC and CD3+CD45+ cell data.
Differences in DNMT1 mRNA expression between GO, SGO
and RASIG
To investigate the possible influence of genetic advantage expected for
GO samples, the analysis of DNMT1 and DNMT3B expression was
performed comparing samples with an age between 54 and 75 years as
GO and SGO were well represented in this age interval. The stratification
by 10-year age groups of subjects aged > 54 years led to a similar
division of GO, SGO and RASIG across the age groups, thus reducing
potential bias due to unequal divisions. As shown in Fig. 2A, the
expression of DNMT1 was significantly higher in RASIG compared to GO
and SGO, while no difference was observed between GO and SGO. The
comparison of DNMT1 expression between age-stratified GO, SGO and
RASIG samples was performed according to gender and recruitment
centre. Data show that the higher level of DNMT1 mRNA in RASIG vs.
GO and SGO seemed to be a common feature, although the statistical
significance was reached in some age/centre subgroups, likely due to
reduced sample size (Table S9). In contrast, the expression levels of
Fig. 1 Age-related changes of DNMT1 and DNMT3B mRNA levels with age in females and males from RASIG population. The picture shows a graphical representation of
DNMT1 and DNMT3B mRNA as log-transformed data vs. age in the RASIG sample. (A1) Dot plot of log-transformed DNMT3B data vs. age in RASIG females; (A2) dot plot of
log-transformed DNMT3B data vs. age in RASIG males; (A3) dot plot of log-transformed DNMT3B data vs. age in all RASIG samples; (B1) dot plot of log-transformed DNMT1
data vs. age in RASIG females; (B2) dot plot of log-transformed DNMT1 data vs. age in RASIG males; (B3) dot plot of log-transformed DNMT1 data vs. age in all RASIG
samples. Correlation coefficients (Pearson R for log-transformed data and Spearman’s rho for untransformed data) are noted below each graph. Significance and 95%
confidence interval of correlation coefficients (within brackets) are estimated by bias-corrected and accelerated (BCa) bootstrap with stratified sampling (1000 samples
stratified for country, and also for gender when all data are used). R-square and significance of the unique relevant quadratic regression is noted above panel B3. Graph and
regression coefficients are also reported considering data of DNMT1 in the age range from 35 to 64 years in RASIG female (panel C1), in RASIG males (panel C2) as well as in
all RASIG population (panel C3).
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DNMT3B were very similar in the three classes of samples (Fig. 2B and
Table S10).
With the aim to trace potential causes for the differences in DNMT1
mRNA expression between GO, SGO and RASIG, the contribution of
selected variables was assessed by GLM analysis (Table 5). Results show
that the differences between the three classes of samples remained
highly significant even when several variables that associated with
interindividual variations in DNMT1 mRNA expression were taken into
account. Additional models that confirmed these results were also run
including all categorized variables associated with DNMT1 in Tables S3–
S5 (Table S11A and 11B).
The effect of batch correction strategies on the association of
DNMT1 and DNMT3B mRNA expression with age and on
differences in DNMT1 mRNA expression between GO, SGO
and RASIG
Our experimental design has been conceived to minimize the impact of
batch effects by the adoption of a validated housekeeping gene for
normalization of expression data in aging (Zampieri et al., 2010) as well
as the use of a calibrator sample to reduce inter-run variation. Clearly,
the presence of additional batch effects could not be completely ruled
out though. In an attempt to address this problem, the age-related
changes in RASIG and the differences between GO, SGO and RASIG of
DNMTs expression were tested against diverse procedures of batch
effects adjustment by the application of a dedicated software. The
following strategies were adopted: (i) simple correction of batch effects;
(ii) correction attempting to retain differences between groups (GO, SGO
and RASIG), age and gender; (iii) group-, age- and gender-sensitive
correction combined with filtering for eventual outliers due to overcor-
rection. As shown in the Fig. S6, the application of the correction
procedures gradually normalized the distribution of data of both DNMTs.
Concerning DNMT1, correction procedures uncovered a weak albeit
significant linear decline with age (Fig. S7). The stratification of data for
age and gender revealed that adjustment for batches mainly affected the
upregulation of DNMT1 in the last age class obtained with unadjusted
data, while a decreasing trend characterized both uncorrected and
corrected data in age groups up to 64 years (Fig. S8). Consistently, a
significant negative linear correlation of DNMT1 expression with age was
Table 3 Influence of selected factors and covariates on age-related changes of
DNMT1 expression†
Variables
Type III
Wald chi-square df Sig.
Age groups 8.760 3 0.033
Gender 0.826 1 0.363
Centre 53.167 6 < 0.001
White bread consumption 6.877 2 0.032
Monocytes 0.123 1 0.726
Ratio lymphocyte to monocyte 19.989 1 < 0.001
Neutrophils 0.240 1 0.624
Model: age groups (o), gender (n), centre (n), white bread consumption (s),
monocytes (s), lymphocytes/monocytes (s), neutrophils (s), (o = ordinal variable:
n = nominal variable; s = scale variable).
†Analysis was performed by GLM using gamma distribution with log-link
function and nontransformed data of the dependent variable: DNMT1
mRNA (s).
Table 4 Regression analysis of DNMT3B expression in females and males from RASIG†
Gender Variables
Coefficients Bootstrap for coefficients
B  SE Beta Bias Sig 95% CI
Model 1 F Age (years) 0.004  0.001 0.086 0.000 0.008 0.007; 0.001
M Age (years) 0.003  0.002 0.059 0.000 0.077 0.006; 0.000
Model 2 F Age (years) 0.004  0.001 0.084 0.000 0.009 0.007; 0.001
Lymphocytes/monocytes 0.293  0.100 0.087 0.004 0.005 0.083; 0.466
M Age (years) 0.002  0.002 0.042 0.000 0.310 0.005; 0.001
Lymphocytes/monocytes 0.190  0.121 0.056 0.001 0.087 0.035; 0.408
Model 3 F Age (years) 0.006  0.002 0.128 0.000 0.001 0.009; 0.002
Lymphocytes/monocytes 0.271  0.131 0.079 0.011 0.021 0.041; 0.525
BMI 0.481  0.111 0.167 0.007 0.001 0.280; 0.671
HDL 0.148  0.073 0.075 0.003 0.047 0.019; 0.278
Monocytes 0.045  0.036 0.048 0.001 0.068 0.102; 0.006
MHC 0.140  0.361 0.013 0.176 0.688 1.417; 0.238
Platelets 0.065  0.052 0.044 0.013 0.385 0.173; 0.133
HGB 0.062  0.234 0.009 0.018 0.801 0.527; 0.445
M Age (years) 0.002  0.002 0.038 0.000 0.302 0.005; 0.002
Lymphocytes/monocytes 0.223  0.152 0.062 0.007 0.145 0.092; 0.524
BMI 0.206  0.163 0.052 0.005 0.161 0.077; 0.507
HDL 0.038  0.088 0.018 0.001 0.690 0.127; 0.222
Monocytes 0.015  0.048 0.013 0.001 0.685 0.083; 0.065
MHC 0.128  0.190 0.025 0.250 0.359 1.594; 0.026
Platelets 0.087  0.059 0.055 0.000 0.109 0.037; 0.215
HGB 0.169  0.262 0.024 0.021 0.482 0.745; 0.407
†Regression analysis was performed by using log-transformed data of dependent and independent variables (with the exclusion of age). All data were included as continuous
variables. Bootstrap results are based on 1000 stratified (by recruitment centre) bootstrap samples. Definition of abbreviations is provided in the Data S2.
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found in the samples up to 64 years independently of correction for
batches (Fig. S9). The batch correction procedure had no relevant impact
on the differences between GO, SGO and RASIG groups even when
considering the major confounding factors in the analysis (Fig. S10). As
DNMT3B concerns, batch correction confirmed and strengthened the
decrement of expression with age (Figs S11 and S12).
Discussion
The mechanisms responsible for the coexistence of global hypomethy-
lation and hypermethylation of specific sequences in the aging genome
are still an open research field. In this context, the altered expression of
DNMTs has long been postulated to contribute to epigenetic instability in
aging. This possibility was mainly prompted by the fact that changes of
DNA methylation patterns and of DNMTs expression are well docu-
mented in aging-associated diseases such as cancer, autoimmune
diseases and Alzheimer’s disease.
The results of pioneering studies, carried out on cellular models of
aging, have shown a substantial change of DNMTs activity with
increasing age due to a combination of maintenance methylation deficit
and increased de novo methylation (Lopatina et al., 2002), events which
were then associated with reduced DNMT1 levels together with
increased DNMT3B, respectively (Casillas et al., 2003). In part, these
initial observations have been further supported by the results of in vivo
studies in humans and mice. In fact, the levels of DNMT1 expression
decrease with age in human T lymphocytes and this is associated with
hypomethylation of specific gene promoters (Zhang et al., 2002; Balada
et al., 2008; Li et al., 2010). By contrast, data on changes of DNMT3B
expression during aging are less concordant since, while its increase was
confirmed in the liver of aged humans (Xiao et al., 2008), a decrease
with age was observed in human T lymphocytes (Balada et al., 2008) as
well as in mouse skin (Qian & Xu, 2014). Collectively, these data indicate
that a transcriptional deregulation of DNMTs would probably accompany
the aging process. However, the available data on humans are derived
from a limited number of correlational studies generally carried out on
relatively small sample sizes.
In the present work, the possible relationship between aging and
expression of DNMT1 and DNMT3B has been tested in the context of a
large-scale population-based study thereby providing, for the first time,
a reference framework for factors that are associated with DNMTs
expression variation such as demographics, clinical laboratory param-
eters as well as dietary and health habits. Using PBMCs, one of the few
accessible tissues, we broadly assessed variation of DNMT1 and
DNMT3B transcript levels in more than two thousand individuals
Fig. 2 Levels of DNMT1 and DNMT3B mRNA in GO, SGO and RASIG. The picture shows a graphical representation of DNMT1 (A) and DNMT3B (B) mRNA level in PBMCs
from GO, SGO and RASIG from the whole MARK-AGE sample above 54 years. Analysis was performed in subjects above 54 years due to nonrepresentative numbers of GO
and SGO below this age. **P < 0.01 from RASIG by post hoc (LSD) of GLM analysis and by KW test performed within each country.
Table 5 Contribution of selected variables and covariates on group (GO, RASIG
and SGO) related changes of DNMT1 expression in PBMCs from population aged
> 54 years†
Tests of model effects
Source
Type III
Wald chi-square df Sig.
Group (GO, SGO, RASIG) 15.707 2 < 0.001
Recruitment centre 78.056 7 < 0.001
Gender 0.041 1 0.839
Age (years) 4.107 1 0.043
BMI 2.565 1 0.109
Serum glucose 0.079 1 0.778
Glycosylated haemoglobin A1C 0.015 1 0.903
Homocysteine 4.236 1 0.040
Neutrophils 1.372 1 0.241
Lymphocytes/monocytes 19.814 1 < 0.001
Monocytes 0.538 1 0.463
WBC 1.179 1 0.278
HCT 0.925 1 0.336
MCV 0.635 1 0.426
MCH 0.064 1 0.801
†Analysis was performed by GLM using gamma distribution with log-link function.
Dependent variable: DNMT1 mRNA. Model: group (n), recruitment centre (n),
gender (n), age (s), BMI (s), serum glucose (s), glycosylated haemoglobin A1C (s),
homocysteine (s), neutrophils (s), lymphocytes/monocytes (s), monocytes (s), WBC
(s), HCT (s), MCV (s), MCH (s); (n = nominal variable; s = scale variable). Definition
of abbreviations is provided in the Data S2.
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recruited across the European population covering the age range of
35–75 years.
Although no substantial correlation was observed between DNMT1
expression and age by linear regression analysis, a significant, but very
small variation of the expression of both transcripts, was found when
samples were stratified into 10-year age groups.
In agreement with previous reports (Zhang et al., 2002; Balada et al.,
2008; Li et al., 2010), the level of DNMT1 gradually dropped with aging.
However, this was observed up to 64 years, where it either appeared to
stabilize (batch corrected data) or to eventually raise again (uncorrected
data) afterwards. Anyway, the U-shaped pattern of the uncorrected
DNMT1 expression data with age in humans is also supported by
observations in a recent publication, where the same trend was observed
for the expression of DNMT1 as well as for the global methylation level
of the genome in mouse liver during aging (Armstrong et al., 2013).
Interestingly, the decrease with age of the methylation levels of
repetitive DNA sequences is not linear in humans either, but it mainly
occurs during ages 40–60 years (Jintaridth & Mutirangura, 2010).
Concerning DNMT3B, its transcript levels decreased with age in
agreement with previous observations in human T lymphocytes (Balada
et al., 2008). Looking at gender, the inverse correlation of DNMT3B
expression with age was significant in the female population.
Notably, the changes with age of both DNMTs within each
recruitment centre were not uniform. While this could be in part
attributed to the reduced sample size, a differential impact of environ-
mental variables on the relationship between expression of DNMTs and
age across different countries cannot be excluded. Significantly,
environmental variables have been described to have an impact on
genomic DNA methylation patterns as well as on DNMTs expression level
(see Zampieri et al., 2015 for review).
We next performed an analysis to examine the association of DNMTs
expression with a large set of variables including demographics, clinical
laboratory parameters, dietary and lifestyle habits.
Concerning demographic variables, an interaction with the expression
of DNMTs was found for gender and BMI in addition to age and country.
Gender differences in the expression of both DNMTs in PBMCs are in
line with data previously obtained in the liver where higher levels of both
DNMT1 and DNMT3B were observed in females (Xiao et al., 2008).
Furthermore, gender-related differences of DNA methylation patterns in
PBMCs have recently been described (Lam et al., 2012). However, our
data suggest that gender differences for DNMT1 are the consequences
of a different proportion in leucocytes subsets.
The positive association of DNMT3B expression with BMI is of great
interest. In fact, an association between BMI and epigenetic age
acceleration was recently observed, especially in liver (Horvath et al.,
2014). In this context, our results would suggest an interesting link
between obesity, altered DNMT3B expression and methylation defects
that predispose to disease. Consistently, enhanced DNMT3B expression
was proposed to contribute to deregulated adipose tissue macrophage
polarization, inflammation and insulin resistance in obesity (Yang et al.,
2014).
Surprisingly, no significant association between dietary habits and level
of DNMTs transcripts was found although increasing evidence indicates
DNA methylation is vulnerable to nutritional influences (Bacalini et al.,
2014). This was also the case of clinical chemistry parameters associated
with cardiovascular and diabetes risk. For some of them, association with
DNMTs expression was found to be indirect and partially explained by
other demographic factors including, but not exclusively, age.
The lack of association between smoking and level of DNMTs was
unexpected considering that cigarette smoking is one of the most
powerful environmental modifiers of the DNA methylation pattern
(Breitling et al., 2011; Lee & Pausova, 2013) and has been shown to
deregulate the expression of DNMTs in brain and lung (Satta et al.,
2008; Lin et al., 2010). This discrepancy could be explained by the fact
that this effect could be tissue-specific and does not concern the PBMCs.
In fact, a lack of statistical association was reported between smoking
and genomewide DNA methylation variation in PBMCs (Lam et al.,
2012) as well as between smoking and epigenetic age acceleration in
multiple tissues (Horvath et al., 2014).
Finally, the expression of DNMTs was influenced by the amount of
lymphocytes, monocytes and by a specific subset of T lymphocytes. This
points to the composition of PBMCs as a confounding factor that may
lead to differences in expression of DNMTs between individuals. Hence,
the study of the relationship between abnormal methylation machinery
and DNA methylation changes in blood cells should take into account
differences in leucocyte composition between individuals. In particular,
the lymphocyte-to-monocyte ratio emerged as the main variable
affecting DNMT1 and DNMT3B. These data also suggest that DNMTs
might be more expressed in lymphocytes than monocytes. Interestingly,
it seems to be the case according to the comparison between blood cell
types of DNMT1 and DNMT3B transcript levels obtained from published
microarray data.
After the identification of variables potentially involved in determining
variations in the expression of DNMTs in our population, we then sought
to determine the impact of these variables on the differences in the
expression of DNMTs between age groups. The results indicate that,
although all the critical variables were taken into account in the analysis,
the differences in the expression of both DNMT1 and DNMT3B between
the age groups are still significant (excluding DNMT3B in the male RASIG
population). This indicates that age affects the expression of DNMTs in
PBMCs as an almost independent variable with respect to all other
variables evaluated here. Nevertheless, factors such as geographical
origin of the samples and lymphocytes-to-monocytes ratio seemed to
have a greater influence on interindividual differences in DNMTs
expression with respect to age in PBMCs. On the other hand, the weak
association of DNMTs expression with age severely limits the possibility
of predicting age by measuring DNMTs transcripts in PBMCs in contrast
to that shown for the methylation status of specific genomic loci
(Horvath, 2013).
The relationship between DNMTs expression and aging was also
evaluated in the GO and SGO populations. GO represents a group of
individuals that is assumed to have genetic benefits for healthy aging
compared to the normal aging population (RASIG) and to their control of
environment and lifestyle (SGO). In this experimental setting, inherent
advantages of GO with respect to aging seem not to be related to
DNMTs expression. In fact, DNMT3B levels were equal between the three
groups while the expression of DNMT1 is even lower in GO with respect
to RASIG. Moreover, GO and SGO showed comparable expression of
DNMT1. This rules out the possibility that the differences in DNMT1
expression between GO and RASIG are due to genetics while it points to
the existence of environmental or lifestyle factors that distinguish GO
and SGO from RASIG. However, differences in expression of DNMT1
between GO, RASIG and SGO do not seem to depend on any of the
variables which we found to be associated with the variation of its
expression in the analysed population. This suggests that GO and SGO
share a similar environmental factor whose influence on the expression
of DNMT1 cannot be traced, at least in any of the parameters analysed
here. A speculative hypothesis could be that the point of contact
between GO and SGO is their microbiome (including bacteria, fungi and
viruses that colonize our organism). In fact, there is evidence that
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cohabitation leads to microbiota similarities between individuals (Song
et al., 2013) and that the centenarians have a very different microbiota
composition from the rest of the population (Biagi et al., 2010; Rampelli
et al., 2013). Notably, differences in intestinal microbiota between
individuals have recently been associated with differences in the pattern
of DNA methylation in the blood (Kumar et al., 2014).
Finally, given that the most significant age-related results of this paper
originated from very small effect sizes, we next sought to determine
whether the aging effect on DNMTs expression was robust to batch
effects. It is expected that batch effects would lead to increased
variability and decreased power to detect a real biological signal. In fact,
in many cases, batch effects increase data variability and can be
confused with an outcome of interest thus leading to misleading
biological conclusions. This claims the necessity to perform dedicated
adjustments especially in population studies that require large sample
sizes and have to be carried over a long time period, as in the case of this
study. However, the application of batch removal tools to our data,
which consisted of heterogeneous (for gender, group and country) small
batches, was likely to introduce additional problems. In fact, in the case
of study groups being nonevenly distributed across batches, algorithms
to remove batch effects may bias group differences, but also carry the
potential concern of removing intragroup biological heterogeneity. In
order to avoid the pitfall deriving from inappropriate batch correction,
diverse approaches have been applied. All adopted procedures con-
firmed the relationship between expression of DNMTs and age.
However, batch correction impacted both the pattern and the strength
of this association. The linear decline of DNMT3B with age was
confirmed and reinforced, as well as the differences in DNMT1
expression between GO, SGO and RASIG, although with a lower
statistical significance. Conversely, removal of batch effects confirmed
the decline of DNMT1 expression up to 65 years while blunted its
upregulation in the last age class obtained with unadjusted data, thus
disproving the U-shaped pattern. However, batch correction appeared to
introduce a possible bias as shown by the preferential impact on the
expression levels of DNMT1 in the 65–75 age class as well as by the
inversion of the mean values between male and females in the same age
class the for both DNMTs. This suggests that the results after correction
should be interpreted with caution.
Collectively, results from this study confirm in large-scale population
setting that aging has an impact on the expression of DNMTs.
Converging evidence is given for the linear decrease of DNMT3B
expression with age as well as for the DNMT1 up to 64 years. For higher
age, data on the trend of DNMT1were conflicting and a possible reading
could be that the decrease of DNMT1 at these ages is attenuated. These
data would form the basis for future investigations aimed at establishing
if these changes are causally linked to variation in DNA methylation
patters and participate to the mechanism of DNA methylation changes
during aging.
Experimental Procedures
Study population, recruitment, data and blood collection
MARK-AGE is a European-wide cross-sectional population study aimed
at the identification of biomarkers of aging (B€urkle et al., 2015; Capri
et al., 2015).
In the present work, the expression of DNMT1 and DNMT3B
transcripts was analysed in PBMCs samples from a total of 2453 donors
in the age range of 35–75 years recruited in eight different European
countries.
Details of the recruitment procedures and of the collection of
anthropometric, clinical and demographic data have been published
(Moreno-Villanueva et al., 2015a,b).
PBMCs isolation procedure has been described (Moreno-Villanueva
et al., 2015a). Briefly, PBMCs were isolated from EDTA-whole blood,
obtained by phlebotomy after overnight fasting, by discontinuous
density gradient centrifugation in Percoll and subsequently cryopre-
served and stored in liquid nitrogen.
Sampleswere then shipped from the various recruitment centres to the
MARK-AGE Biobank located at the University of Hohenheim, Stuttgart,
Germany. From theBiobank, coded sampleswere subsequently sent to the
Sapienza University of Rome on dry-ice where they were stored in liquid
nitrogen until analysis of the DNMT1 and DNMT3BmRNA levels.
RNA extraction and cDNA synthesis
Samples were thawed by incubation at 37°C, followed by drop wise
addition of RPMI containing 10% FCS to a final dilution of 1:20. Cells
were collected by centrifugation and processed for RNA extraction.
Isolation of total RNA was performed using RNeasy Mini Kit (Qiagen,
Hilden, Germany) according to the manufacturer’s instructions and
subjected to DNase I digestion using RNase-free DNase (Qiagen, Hilden,
Germany). RNA concentration, purity and integrity were evaluated as
previously described (Zampieri et al., 2010). Reverse transcription was
carried out using the SuperScript VILO cDNA Synthesis Kit (Invitrogen,
MA, USA) on equal amounts of total RNA (0.5 lg).
Real-time quantitative RT–PCR
The expression of DNMT1 and DNMT3B was determined by quantitative
PCR using the Taqman Gene Expression Assays (Applied Biosystems, CA,
USA) following the manufacturer’s protocol on the iCycler IQ detection
system (Bio-Rad, Hercules, CA, USA). The PCR efficiency for each gene
assay was tested using twofold serial dilutions (from 50 to 3.125 ng) of
cDNAs randomly chosen fromamong the samples. Each set of primers and
probe showed an efficiency of 90–100%. All calibration curves exhibited
correlation coefficients > 0.99. Assays were performed in triplicate with
cDNA equivalent to 30 ng of reverse transcribed RNA. Gene expression
analysiswas performedby the relative calibrator normalized quantification
method using the expression level of the b-glucuronidase gene (GUSB) as
reference (Zampieri et al., 2010). An inter-run calibration samplewas used
in all plates to correct for the technical variance between the different runs
and to compare results from different plates. The calibrator consisted of
cDNA prepared from HCT116 cells. The Taqman Gene Expression Assays
IDs for each set of primers and probe were as follows: Hs00154749_m1
(DNMT1), Hs00171876_m1 (DNMT3B), Hs99999908_m1 (GUSB). The
data obtained were uploaded to the MARK-AGE database (Moreno-
Villanueva et al., 2015b), established at the University of Konstanz
(Konstanz, Germany), where they were recorded, curated and merged
with the anthropometric, clinical and demographic data elements of
donors.
Statistical analysis
See supporting information.
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